Suppr超能文献

糠酸氟替卡松、溴化乌美溴铵和三氟乙酸维兰特罗固定剂量组合的空气动力学特性及共沉积的体外分析

In Vitro Analysis of Aerodynamic Properties and Co-Deposition of a Fixed-Dose Combination of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol Trifenatate.

作者信息

Maneechotesuwan Kittipong, Sawatdee Somchai, Srichana Teerapol

机构信息

Department of Medicine, Division of Respiratory Disease and Tuberculosis, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

Drug and Cosmetics Excellence Center and School of Pharmacy, Walailak University, Thasala, Nakhon Si Thammarat 80161, Thailand.

出版信息

Pharmaceutics. 2024 Oct 18;16(10):1334. doi: 10.3390/pharmaceutics16101334.

Abstract

BACKGROUND/OBJECTIVES: Effective airway delivery of a fixed-dose combination of triple-aerosolized inhaled corticosteroid (ICS)/long-acting beta agonist (LABA)/long-acting muscarinic antagonist (LAMA) is likely to positively affect therapeutic responses predicted in patients with asthma and chronic obstructive pulmonary disease. This study aimed to conduct in vitro fluticasone furoate, vilanterol trifenatate, and umeclidinium bromide depositions in a Next Generation Impactor. The aerodynamic properties of these inhaled medications influence the spatial distribution and drug abundance, particularly in the smaller airways, to reverse or alleviate disease pathology.

METHODS

The Next Generation Impactor was used to demonstrate the aerodynamic particle size distributions of fluticasone furoate, vilanterol trifenatate, and umeclidinium bromide delivered from a dry powder inhaler at different flow rates across all stages of the impactors. This in vitro study analyzed the distribution pattern of individual drug components to simulate mono-component deposition and co-deposition in the official model in the United States Pharmacopeia. An Andersen cascade impactor together with scanning electron microscope-energy-dispersive X-ray was employed to observe the drug deposition on each stage of the impactor.

RESULTS

We found that the distribution pattern of each component at the same cascade level was comparable, and the aerosol particles of the three drugs reached the in vitro representation of the lower airway compartment. The specified flow rates generated the desired fine particle fraction, fine particle dose, and mass median aerodynamic diameter. Our results also demonstrated visualized deposition patterns of the delivered drugs from different stages of the cascade impactor that may predict deposition as it occurs in vivo.

CONCLUSIONS

Spatial distribution and abundance of ICS/LABA/LAMA in the same cascade levels were closely comparable, and the aerosol particles were able to reach the small aerosol-sized cascades at the lower levels to some extent.

摘要

背景/目的:三联雾化吸入糖皮质激素(ICS)/长效β受体激动剂(LABA)/长效毒蕈碱拮抗剂(LAMA)固定剂量组合经气道有效给药,可能会对哮喘和慢性阻塞性肺疾病患者的预期治疗反应产生积极影响。本研究旨在通过下一代撞击器测定糠酸氟替卡松、三苯乙酸维兰特罗和乌美溴铵的体外沉积情况。这些吸入药物的空气动力学特性会影响空间分布和药物丰度,尤其是在小气道中,从而逆转或减轻疾病病理状态。

方法

使用下一代撞击器,以不同流速展示从干粉吸入器递送的糠酸氟替卡松、三苯乙酸维兰特罗和乌美溴铵在撞击器各阶段的空气动力学粒径分布。这项体外研究分析了各个药物成分的分布模式,以模拟在美国药典官方模型中的单组分沉积和共沉积情况。采用安德森级联撞击器结合扫描电子显微镜 - 能量色散X射线,观察药物在撞击器各阶段的沉积情况。

结果

我们发现,在相同级联水平下各成分的分布模式具有可比性,三种药物的气溶胶颗粒达到了下呼吸道隔室的体外表现形式。特定流速产生了所需的细颗粒分数、细颗粒剂量和质量中值空气动力学直径。我们的结果还展示了级联撞击器不同阶段递送药物的可视化沉积模式,这可能预测体内发生的沉积情况。

结论

ICS/LABA/LAMA在相同级联水平下的空间分布和丰度密切可比,并且气溶胶颗粒能够在一定程度上到达较低水平的小气溶胶尺寸级联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c29/11510472/aea1de1d1df6/pharmaceutics-16-01334-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验